Clinical trials recruiting for Stage IV Prostate Cancer AJCC v8
14
Recruiting trials
43
US states with sites
5
Countries
7%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 5 |
| Arizona | 4 |
| Florida | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Minnesota | 2 |
| Utah | 2 |
| Wisconsin | 2 |
| Arkansas | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Delaware | 1 |
Top cities
Scottsdale, Arizona 4Duarte, California 3Houston, Texas 3Jacksonville, Florida 3Philadelphia, Pennsylvania 3Eau Claire, Wisconsin 2La Crosse, Wisconsin 2Rochester, Minnesota 2Sacramento, California 2Salt Lake City, Utah 2
Self-screener
Recruiting trials
- Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
- Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
- Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
- Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
- Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
- Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
- Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
- SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Related conditions
Trials recruiting for Stage IV Prostate Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Stage IVB Prostate Cancer AJCC v8 27Stage IVA Prostate Cancer AJCC v8 13Stage III Prostate Cancer AJCC v8 19Metastatic Prostate Carcinoma 13Metastatic Prostate Adenocarcinoma 13Castration-Resistant Prostate Carcinoma 13Biochemically Recurrent Prostate Carcinoma 6Stage IIC Prostate Cancer AJCC v8 5Stage IVC Colorectal Cancer AJCC v8 7
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage IV Prostate Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.